C137H172F3N15O16 — CID 158160248
(2S)-N-[(1S)-1-[2-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]-4-pyridinyl]-3-oxobutyl]-4-methyl-2-(4-methyl-2-oxo-1-pyridinyl)pentanamide;(2S)-4-methyl-N-[(1S)-1-[4-methyl-3-(2-methylphenyl)phenyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-[2-(2-methylphenyl)-4-pyridinyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-(4-methyl-3-piperidin-1-ylphenyl)-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;(3S)-3-[[4-methyl-2-(2-oxopiperidin-1-yl)pentanoyl]amino]-3-[5-(2-methylphenyl)-6-(trifluoromethyl)-3-pyridinyl]propanoic acid (PubChem CID 158160248) has the molecular formula C137H172F3N15O16 and a molecular weight of 2341.97 g/mol. Its IUPAC name is (2S)-N-[(1S)-1-[2-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]-4-pyridinyl]-3-oxobutyl]-4-methyl-2-(4-methyl-2-oxo-1-pyridinyl)pentanamide;(2S)-4-methyl-N-[(1S)-1-[4-methyl-3-(2-methylphenyl)phenyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-[2-(2-methylphenyl)-4-pyridinyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-(4-methyl-3-piperidin-1-ylphenyl)-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;(3S)-3-[[4-methyl-2-(2-oxopiperidin-1-yl)pentanoyl]amino]-3-[5-(2-methylphenyl)-6-(trifluoromethyl)-3-pyridinyl]propanoic acid.
| Compound Name | (2S)-N-[(1S)-1-[2-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]-4-pyridinyl]-3-oxobutyl]-4-methyl-2-(4-methyl-2-oxo-1-pyridinyl)pentanamide;(2S)-4-methyl-N-[(1S)-1-[4-methyl-3-(2-methylphenyl)phenyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-[2-(2-methylphenyl)-4-pyridinyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-(4-methyl-3-piperidin-1-ylphenyl)-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;(3S)-3-[[4-methyl-2-(2-oxopiperidin-1-yl)pentanoyl]amino]-3-[5-(2-methylphenyl)-6-(trifluoromethyl)-3-pyridinyl]propanoic acid |
|---|---|
| PubChem CID | 158160248 |
| Molecular Formula | C137H172F3N15O16 |
| Molecular Weight | 2341.97 g/mol |
| Exact Mass | 2340.31 |
| IUPAC Name | (2S)-N-[(1S)-1-[2-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]-4-pyridinyl]-3-oxobutyl]-4-methyl-2-(4-methyl-2-oxo-1-pyridinyl)pentanamide;(2S)-4-methyl-N-[(1S)-1-[4-methyl-3-(2-methylphenyl)phenyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-[2-(2-methylphenyl)-4-pyridinyl]-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;4-methyl-N-[(1S)-1-(4-methyl-3-piperidin-1-ylphenyl)-3-oxobutyl]-2-(2-oxo-1-pyridinyl)pentanamide;(3S)-3-[[4-methyl-2-(2-oxopiperidin-1-yl)pentanoyl]amino]-3-[5-(2-methylphenyl)-6-(trifluoromethyl)-3-pyridinyl]propanoic acid |
| SMILES | CC(=O)C[C@H](NC(=O)C(CC(C)C)n1ccccc1=O)c1ccc(C)c(N2CCCCC2)c1.CC(=O)C[C@H](NC(=O)C(CC(C)C)n1ccccc1=O)c1ccnc(-c2ccccc2C)c1.CC(=O)C[C@H](NC(=O)[C@H](CC(C)C)n1ccc(C)cc1=O)c1ccnc(N2[C@H](C)CC[C@@H]2C)c1.CC(=O)C[C@H](NC(=O)[C@H](CC(C)C)n1ccccc1=O)c1ccc(C)c(-c2ccccc2C)c1.Cc1ccccc1-c1cc([C@H](CC(=O)O)NC(=O)C(CC(C)C)N2CCCCC2=O)cnc1C(F)(F)F |
| InChI | InChI=1S/C29H34N2O3.C27H32F3N3O4.C27H38N4O3.C27H37N3O3.C27H31N3O3/c1-19(2)16-27(31-15-9-8-12-28(31)33)29(34)30-26(17-22(5)32)23-14-13-21(4)25(18-23)24-11-7-6-10-20(24)3;1-16(2)12-22(33-11-7-6-10-23(33)34)26(37)32-21(14-24(35)36)18-13-20(19-9-5-4-8-17(19)3)25(31-15-18)27(28,29)30;1-17(2)13-24(30-12-10-18(3)14-26(30)33)27(34)29-23(15-21(6)32)22-9-11-28-25(16-22)31-19(4)7-8-20(31)5;1-19(2)16-25(30-15-9-6-10-26(30)32)27(33)28-23(17-21(4)31)22-12-11-20(3)24(18-22)29-13-7-5-8-14-29;1-18(2)15-25(30-14-8-7-11-26(30)32)27(33)29-23(16-20(4)31)21-12-13-28-24(17-21)22-10-6-5-9-19(22)3/h6-15,18-19,26-27H,16-17H2,1-5H3,(H,30,34);4-5,8-9,13,15-16,21-22H,6-7,10-12,14H2,1-3H3,(H,32,37)(H,35,36);9-12,14,16-17,19-20,23-24H,7-8,13,15H2,1-6H3,(H,29,34);6,9-12,15,18-19,23,25H,5,7-8,13-14,16-17H2,1-4H3,(H,28,33);5-14,17-18,23,25H,15-16H2,1-4H3,(H,29,33)/t26-,27-;21-,22?;19-,20+,23-,24-;2*23-,25?/m00000/s1 |
| InChIKey | FWEHDNFMFWPIQP-MQEJKCNPSA-N |
| XLogP | 24.26 |
| TPSA | 404.54 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 45 |
| Heavy Atoms | 171 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2341.97 |
| LogP ≤ 5 | 24.26 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 24 |